UK market access Peter Kuiper, general manager UK & Ireland at Sanofi Genzyme said the European Commission ... plan to submit the drug to the FDA for this use by the end of 2017.

Under the new structure, due to come into effect next January, Sanofi's cancer and immunology pipeline with now sit alongside subsidiary Genzyme's rare disease and multiple sclerosis (MS ...